PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $184,200 | -1.9% | 30,000 | 0.0% | 0.02% | +109.1% |
Q2 2023 | $187,800 | +57.5% | 30,000 | +20.0% | 0.01% | -26.7% |
Q1 2023 | $119,250 | -31.5% | 25,000 | +25.0% | 0.02% | -37.5% |
Q4 2022 | $174,000 | -99.9% | 20,000 | +100.0% | 0.02% | +41.2% |
Q3 2022 | $119,000,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |